NCT04351347View on ClinicalTrials.gov

The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

June 16, 2020

Primary Completion Date

December 1, 2030

Study Completion Date

December 1, 2030

Conditions

COVID

Interventions

DRUG

Ivermectin

ivermectin

Trial Locations (1)

35111

RECRUITING

Tanta University, Tanta

All Listed Sponsors

lead

Tanta University

OTHER